The need of mycophenolic acid monitoring in long-term renal transplants

Clinical Transplantation

Volumn 19, Issue 1, 2005, Pages 19-25

  David Neto, Elias ^a,b   Pereira, Lilian M ^a   Kakehashi, Erica ^a   Sumita, Nario M ^a   Mendes, Maria E ^a   Castro, Maria C R ^a   Romano, Paschoalina ^a   Mattos, Renata M ^a   Batista, Vania R M ^a   Nahas, William C ^a   Ianhez, Luiz E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Univ of Sao Paolo Sch of Medicine ^*  (Brazil)

Author keywords

Area under the time; Concentration curve; Mycophenolate mofetil; Mycophenolic acid; Pharmacokinetics; Renal transplantation; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EXPOSURE; DRUG MONITORING; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; PREDICTION; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; DRUG MONITORING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 13644249459     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00260.x     Document Type: Article

References (25)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000: 342: 605.
2. European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999: 68: 391.
3. Ojo AO, Meier-Kriesche HU, Hanson JA et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection [see comments]. Transplantation 2000: 69: 2405.
4. Weir MR, Anderson L, Fink JC et al. A novel approach to the treatment of chronic allograft nephropathy. Transplantation 1997: 64: 1706.
5. David-Neto E, Araujo LM, Lemos FC et al. Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy. Pediatr Transplant 2001: 5: 302.
6. Weber LT, Shipkova M, Armstrong VW et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002: 13: 759.
7. Shaw LM, Kaplan B, De Nofrio D, Korecka M, Brayman KL. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000: 22: 14.
8. Mourad M, Malaise J, Chaib Eddour D et al. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with TACimus in kidney transplantation. Clin Chem 2001: 47: 1241.
9. Weber LT, Shipkova M, Armstrong VW et al. Comparison of the EMIT immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Clin Chem 2002: 48: 517.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986: 1: 307.
11. Le Guellec C, Buchler M, Giraudeau B et al. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol 2002: 57: 805.
12. Engelbertink R, Smak Gregoor P, Hesse C, Weimar W, van Gelder T. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment. Transplant Proc 2002: 34: 2983.
13. Budde K, Braun KP, Glander P et al. Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients. Transplant Proc 2002: 34: 1748.
14. Cattaneo D, Gaspari F, Ferrari S et al. Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients. Clin Transplant 2001: 15: 402.
15. Pelletier RP, Akin B, Henry ML et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 2003: 17: 200
16. Filler G, Zimmering M, Mai I. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Pediatr Nephrol 2000: 14: 100.
17. van Gelder T, Smak Gregoor PJ, Weimar W. Drug interaction between mycophenolate mofetil and TACimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. Ther Drug Monit 2000: 22: 639.
18. Hubner GI, Eismann R, Sziegoleit W. Drug interaction between mycophenolate mofetil and TACimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. Ther Drug Monit 1999: 21: 536.
19. Brunet M, Martorell J, Oppenheimer F et al. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil. Transpl Int 2000: 13(Suppl. 1): S301.
20. Jacqz-Aigrain E, Khan Shaghaghi E, Baudouin V et al. Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children. Pediatr Nephrol 2000: 14: 95.
21. David-Neto E, Araujo LM, Sumitda NM et al. Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation. Pediatr Nephrol 2003: 18: 266.
22. Weber LT, Schutz E, Lamersdorf T et al. Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients - a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) Therapy. Nephrol Dial Transplant 1999: 14: 33.
23. Glander J, Hambach P, Mai L et al. Pharmacokinetic and pharmacodynamic monitoring of renal allograft recipients treated with mycophenolate mofetil (Abstract). Am J Transplant 2003: 3: 210.
24. Lemos FBC, Ianhez LE, Sabbaga E, David-Neto E. Is the improvement of renal function in chronic allograft nephropathy, after MMF introduction, related to cyclosporin A reduction? (Abstract). Transplantation 1999: 67: S.
25. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant TACimus. Clin Chem 2002: 48: 1497.